Effect of pneumococcal conjugate vaccines on mortality from lower respiratory infections and pneumonia among under-fives

References

• Styblo K, Meijer J, Sutherland I. La transmission du bacilli tuberculeux: son evolution au sein d’une collectivité humaine. Bull World Health Organ. 1969;41:137–78. [Articlein French; Summary available in English].
   PubMedGoogle Scholar
• Kass EH. Infectious diseases and social change. J Infect Dis. 1971;123(1):110–14. doi:10.1093/infdis/123.1.110.
   PubMed Web of Science ®Google Scholar
• Camargos PA, Guimarães MD, Antunes CM. Risk assessment for acquiring meningitis tuberculosis among children not vaccinated with BCG: a case-control study. Int J Epidemiol. 1988;17(1):193–97. doi:10.1093/ije/17.1.193.
   PubMed Web of Science ®Google Scholar
• Wagner KS, White JM, Andrews NJ, Borrow R, Stanford E, Newton E, Pebody RG. Immunity to tetanus and diphtheria in the UK in 2009. Vaccine. 2012;30(49):7111–17. doi:10.1016/j.vaccine.2012.09.029.
   PubMed Web of Science ®Google Scholar
• Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2020 Apr 20;4:CD004407. doi:10.1002/14651858.CD004407.pub4.
   PubMedGoogle Scholar
• GBD 2017 Lower Respiratory Infections Collaborators. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2020;20(1):60–79. doi:10.1016/S1473-3099(19)30410-4.
   PubMed Web of Science ®Google Scholar
• GBD 2016 lower respiratory infections collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191–210. doi:10.1016/S1473-3099(18)30310-4.
   PubMed Web of Science ®Google Scholar
• Cutts FT, Zaman SMA, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005;365(9465):1139–46. doi:10.1016/S0140-6736(05)71876-6.
   PubMed Web of Science ®Google Scholar
• Suarez V, Michel F, Toscano CM, Bierrenbach AL, Gonzales M, Alencar AP, Ruiz Matus C, Andrus JK, de Oliveira LH. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: time series analyses. Vaccine. 2016;34(39):4738–43. doi:10.1016/j.vaccine.2016.07.027.
   PubMed Web of Science ®Google Scholar
• Diaz J, Terrazas S, Bierrenbach AL, Toscano CM, Alencar GP, Alvarez A, Valenzuela MT, Andrus J, Del Aguila R, Hormazábal JC, et al. Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in children in Chile: a nested case-control study using nationwide pneumonia morbidity and mortality surveillance data. PLoS One. 2016;11(4):e0153141. doi:10.1371/journal.pone.0153141.
   PubMed Web of Science ®Google Scholar
• Kupek E, Vieira IL. Impact of PCV10 pneumococcal vaccine on mortality from pneumonia in children less than one year of age in Santa Catarina State, Brazil. Cad Saúde Publica. 2016;32(3):e00131414. doi:10.1590/0102-311X00131414.
   PubMed Web of Science ®Google Scholar
• von Mollendorf C, Tempia S, von Gottberg A, Meiring S, Quan V, Feldman C, Cloete J, Madhi SA, O’Brien KL, Klugman KP, et al. Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa. PLoS One. 2017;12(7):e0179905. doi:10.1371/journal.pone.0179905.
   PubMed Web of Science ®Google Scholar
• Schuck-Paim C, Taylor RJ, Alonso WJ, Weinberger DM, Simonsen L. Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study. Lancet Glob Health. 2019;7(2):e249–56. doi:10.1016/S2214-109X(18)30455-8.
   PubMed Web of Science ®Google Scholar
• Camargos P, Nascimento-Carvalho CM, Teixeira R, França E. Lower respiratory infections mortality among Brazilians under-five before and after national pneumococcal conjugate vaccine implementation. Vaccine. 2020;38(11):2559–65. doi:10.1016/j.vaccine.2020.01.084.
   PubMed Web of Science ®Google Scholar
• GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–88. doi:10.1016/S0140-6736(18)32203-7.
   PubMed Web of Science ®Google Scholar
• GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1084–150. doi:10.1016/S0140-6736(17)31833-0.
   PubMed Web of Science ®Google Scholar
• GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–210. doi:10.1016/S0140-6736(17)32152-9.
   PubMed Web of Science ®Google Scholar
• Koelman DLH, Brouwer MC, van de Beek D. Resurgence of pneumococcal meningitis in Europe and Northern America. Clin Microbiol Infect. 2020 Feb;26(2):199–204. doi:10.1016/j.cmi.2019.04.032.
   PubMed Web of Science ®Google Scholar